Chronic Treatment of Alzheimer's Disease by Gamma Light and Sound Therapy
RecruitingNCT05655195Phase: NAStarted 2022-12-14
Summary
Alzheimer's disease (AD) is characterized by significant memory loss, toxic protein deposits amyloid and tau) in the brain, and changes in the gamma frequency band on EEG. The investigator's lab found
Eligibility
Sex
ALL
Min Age
65 Years
Max Age
100 Years
Locations
Massachusetts Institute of TechnologyCambridge, Massachusetts, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT05655195